上市公司把民间验方做成了戒毒药？官宣后股价下跌

Group 1 - The core product, Duanjin Detox Capsule, is developed based on folk remedies for treating opioid addiction and preventing relapse, with key ingredients including Kouwen and Yangjinhua [2] - The clinical trial results indicate that the product met its expected goals, showing significant efficacy in detoxification and relapse prevention, with a one-year relapse rate potentially as low as 30% [2] - The company reported high relapse rates among heroin users, with 77.7% relapsing within three months and over 95% within six months after detoxification [2] Group 2 - The company has applied for breakthrough therapy designation for the product, with an expected approval result around September 20, 2023, following a 45-working-day review period [2] - There are uncertainties regarding the approval from the National Medical Products Administration for market launch, and the company will actively promote the research project in accordance with national regulations [3]